The recent policy change regarding cannabis, announced by the National Basketball Association (NBA) and the National Basketball Players Association (NBPA), presents new opportunities for players.
Athletes may engage in investments, endorsements, and sponsorships within the evolving legal cannabis industry, but caution is necessary, lawyers tell Bloomberg Law.
See Also: NBA Drops Cannabis Testing For Players, Can The NFL Be Far Behind?
For example, there are reputational risks since cannabis still carries a stigma and remains federally illegal.
Player endorsements of cannabis products could be viewed as promoting drug use, potentially harming their reputation and future endorsement prospects.
Legal concerns may also arise if players face legal repercussions if they invest in companies operating in states where marijuana remains illegal. Similarly, cannabis companies could encounter legal issues by selling athlete-endorsed products in states with strict regulations governing celebrity endorsements and marketing.
Regulatory challenges are another factor to consider. Players entering partnerships with cannabis companies may encounter obstacles or even violate the law if proper precautions are not taken.
Conflicts of interest could arise if players' financial interests clash with NBA policies, and lack of experience in investing or business partnerships may pose additional challenges, explained Fox Rothschild’s Vijay Choksi and Cameron Baker.
Under the new agreement, players are allowed to invest in CBD companies and hold active, controlling interests in such businesses. However, they are prohibited from holding active, controlling interests in companies producing marijuana with THC levels exceeding 0.3%. Similarly, while CBD product promotion is permitted, endorsing marijuana products containing THC above 0.3% remains restricted.
Read Now: NBA's Historic Agreement Lifts Marijuana Ban, Allows Players To Invest In Companies
Photo: Courtesy Of MontyLov On Unsplash
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!